Drugs & medicalClass II

Aurobindo Pharma USA Inc recalls Acetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, NDC…

cGMP deviations: Due to confirmed consumer complaints received with the observation of tablet discoloration (brown surface on tablets).

Read the official notice →
Date
2025-06-25
Country
United States
Brand
Aurobindo Pharma
Product
Acetaminophen Tablets, 325 mg, 100-count bottles, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N., Seattle, WA 98109, NDC…
Classification
Class II
Units
USA Nationwide.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Aurobindo Pharma recalls

  1. 2026-10-07
  2. US
    Drugs & medicalNot Yet Classified

    Aurobindo Pharma USA Inc recalls amazon, Acetaminophen, Extra Strength, 500mg Caplets, 1000-count bottle, Distributed by: Amazon.com Services LLC, 410 Terry Avenue N.,…

    Discoloration: consumer complaints received for discolored tablets

    FDA · DrugAurobindo Pharma USA IncUS Nationwide.Official notice →
  3. 2026-08-12
  4. US
  5. 2024-12-25
  6. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

    FDA · DrugAurobindo Pharma USA IncNationwide in the USAOfficial notice →
  7. 2024-12-11
  8. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only,…

    cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

    FDA · DrugAurobindo Pharma USA IncUSA NationwideOfficial notice →
  9. 2024-08-28
  10. US
    Drugs & medicalClass I

    Aurobindo Pharma USA Inc recalls Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by:…

    Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

    FDA · DrugAurobindo Pharma USA IncNJ, NY & PAOfficial notice →
  11. 2024-05-15
  12. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC…

    Discoloration: Dotted and yellow spots on tablets

    FDA · DrugAurobindo Pharma USA Inc.Nationwide in the USAOfficial notice →
All 15 Aurobindo Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2025-06-25
  2. US
    Drugs & medicalClass I

    Cook Incorporated recalls Beacon Tip 5.0 Fr Angiographic catheters are designed to facilitate diagnostic and therapeutic procedures. Catheters are available in…

    Cook Medical identified that catheters supplied in the affected device lots may experience tip separation.

    FDA · DeviceCook IncorporatedWorldwide distribution.Official notice →
  3. US
    Drugs & medicalClass I

    Umary-USA.com recalls UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295

    Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

    FDA · DrugUmary-USA.comU.S. Nationwide via internet.Official notice →
  4. US
    Drugs & medicalClass II

    Eugia US LLC recalls Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC,…

    Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

    FDA · DrugEugia US LLCNationwide in the USAOfficial notice →
  5. 2025-06-18
  6. US
    Drugs & medicalClass II

    MicroAire Surgical Instruments, LLC recalls Brand Name: SmartRelease ESTR (Endoscopic soft tissue release system), Onyx Blade Assembly; alternate name: ECTR (Endoscopic…

    Potential that the blade can unintentionally cut tissue prior to the user deploying the blade.

    FDA · DeviceMicroAire Surgical Instruments, LLCWorldwide distribution - US Nationwide and the countries of Denmark, United…Official notice →
  7. US
    Drugs & medicalClass II

    BD SWITZERLAND SARL recalls BD TEXIUM CLOSED MALE LUER WITH FEMALE CAP, REF: 10012241-0500

    Sterile, single use closed system drug transfer devices, standalone or on infusion sets or bonded syringes, may leak at the interface between the closed male luer component and the needle-free connector, which may…

    FDA · DeviceBD SWITZERLAND SARLWorldwide - US Nationwide distribution including in the states of MA, CA, IL,…Official notice →
  8. US
    Drugs & medicalClass II

    PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. recalls Azurion R1.x and R2.x systems; Model Numbers: (1) 722063, (2) 722064, (3) 722067, (4) 722068, (5) 722078, (6) 722079, (7)…

    A software issue was identified in the internal communication process between the system software and the X-ray generator firmware. Loss of imaging (X-ray) functionality caused by the software issue in either of the…

    FDA · DevicePHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Worldwide distribution - US Nationwide and the countries of Afghanistan,…Official notice →
See all drugs & medical recalls →